Simplex Trading, LLC Immuno Gen, Inc. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$12.46 - $29.95 $12,048 - $28,961	967 Added 0.46%	211,467 $6.27 Million
Q3 2023 Nov 01, 2023	SELL	$14.09 - $19.87 $1.35 Million - $1.9 Million	-95,478 Reduced 31.2%	210,500 $3.34 Million
Q2 2023 Aug 04, 2023	BUY	$3.75 - $20.05 $701,122 - $3.75 Million	186,966 Added 157.1%	305,978 $5.77 Million
Q1 2023 Apr 27, 2023	BUY	$3.67 - $4.92 $210,408 - $282,073	57,332 Added 92.95%	119,012 $457,000
Q4 2022 Feb 02, 2023	BUY	$4.55 - $6.31 $77,695 - $107,749	17,076 Added 38.28%	61,680 $305,000
Q3 2022 Nov 04, 2022	SELL	$4.48 - $6.47 $137,858 - $199,094	-30,772 Reduced 40.82%	44,604 $213,000
Q2 2022 Aug 03, 2022	SELL	$3.15 - $5.76 $128,879 - $235,664	-40,914 Reduced 35.18%	75,376 $339,000
Q1 2022 May 02, 2022	BUY	$4.26 - $7.48 $141,547 - $248,537	33,227 Added 40.0%	116,290 $553,000
Q4 2021 Feb 23, 2022	BUY	$4.75 - $7.5 $290,524 - $458,722	61,163 Added 279.28%	83,063 $616,000
Q2 2021 Aug 12, 2021	BUY	$5.79 - $8.6 $126,801 - $188,340	21,900 New	21,900 $144,000
Q2 2020 Jul 13, 2020	SELL	$3.32 - $5.34 $54,521 - $87,693	-16,422 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$2.12 - $6.8 $4,167 - $13,368	-1,966 Reduced 10.69%	16,422 $55,000
Q4 2019 Feb 05, 2020	BUY	$2.25 - $5.8 $39,834 - $102,683	17,704 Added 2588.3%	18,388 $93,000
Q3 2019 Oct 15, 2019	SELL	$2.22 - $3.39 $18,301 - $27,947	-8,244 Reduced 92.34%	684 $1,000
Q2 2019 Jul 26, 2019	SELL	$1.8 - $3.3 $74,889 - $137,296	-41,605 Reduced 82.33%	8,928 $19,000
Q1 2019 Apr 18, 2019	BUY	$2.41 - $5.91 $38,278 - $93,868	15,883 Added 45.84%	50,533 $0
Q4 2018 Jan 16, 2019	SELL	$3.94 - $9.7 $42,343 - $104,245	-10,747 Reduced 23.67%	34,650 $166,000
Q3 2018 Oct 23, 2018	BUY	$8.6 - $11.26 $140,360 - $183,774	16,321 Added 56.13%	45,397 $429,000
Q2 2018 Jul 30, 2018	BUY	$9.52 - $12.15 $276,803 - $353,273	29,076 New	29,076 $282,000
Q1 2018 Apr 26, 2018	SELL	$6.7 - $12.95 $182,695 - $353,120	-27,268 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$5.07 - $7.92 $138,248 - $215,962	27,268	27,268 $174,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account